Skip to main content
. 2013 Oct 9;4:297. doi: 10.3389/fmicb.2013.00297

Table 1.

The MICs of M. haemolytica isolated from the nasopharynx of feedlot cattlea

Antibiotic (concentrations tested, μg/mL) Isolate
32A 32B 32C 50A 55A
Ampicillin (0.25, 0.5, 1, 2, 4, 8, 16*) 0.25 0.25 0.25 0.25 >16
Ceftiofur (0.25, 0.5, 1, 2, 4, 8b) 0.25 0.25 0.25 0.25 0.5
Chlortetracycline (0.5, 1, 2, 4, 8) 4 4 2 2 2
Clindamycin (0.25, 0.5, 1, 2, 4, 8, 16) 16 16 16 16 16
Danofloxacin (0.12, 0.25b, 0.5, 1) 0.12 0.12 0.12 0.12 0.12
Enrofloxacin (0.12, 0.25, 0.5, 1, 2b) 0.12 0.12 0.12 0.12 0.12
Florfenicol (0.25, 0.5, 1, 2, 4, 8b) 1 1 1 1 0.5
Gentamycin (1, 2, 4, 8, 16) 2 2 2 2 2
Neomycin (4, 8, 16, 32*) >32 >32 >32 >32 >32
Oxytetracycline (0.5, 1, 2, 4, 8b) >8 >8 >8 >8 >8
Penicillin (0.12, 0.25, 0.5, 1, 2, 4, 8*) 0.12 0.12 0.25 0.25 >8
Spectinomycin (8, 16, 32, 64) 32 32 32 32 32
Tiamulin (0.5, 1, 2, 4, 8, 16, 32) 32 32 32 32 16
Tilmicosin (4, 8, 16, 32b, 64) 64 64 64 >64 >64
Tulathromycin (1, 2, 4, 8, 16, 32, 64b) 64 64 64 64 64
Tylosin tartrate 0.5, 1, 2, 4, 8, 16, 32) >32 >32 >32 >32 >32
a

Isolates were first screened for reduced tulathromycin susceptibility by culturing onto BHI plates supplemented with tulathromycin (2 μg/mL).

b

Breakpoints defining resistance (CLSI, 2008).

*

Resistance breakpoint defined by authors.